selected scholarly activity
-
conferences
- A comparison of portal dosimetry for the Varian Halcyon 2.0 and multiple detector systems. Medical Physics. 5691-5691. 2022
- The Canadian experience in commissioning a Halcyon-Linac in a Pinnacle-MOSAIQ based centre. Medical Physics. 5692-5692. 2022
- XRF analysis of arsenic‐doped skin phantoms. X-Ray Spectrometry. 285-288. 2004
-
journal articles
- Streamlining Regulatory Activities Within Radiation Therapy Departments Using QATrack+. Health Physics. 117:306-312. 2019
- Current Practice in Total-Body Irradiation: Results of a Canada-Wide Survey. Current Oncology. 24:181-186. 2017
- SU‐E‐T‐404: The Effect of Field/target Size on Quality Assurance of TomoTherapy IMRT Treatments When Using a Diode Array for Absolute and Relative Dose Measurements. Medical Physics. 38:3581-3581. 2011
- MOSFET detectors in quality assurance of tomotherapy treatments. Radiotherapy and Oncology. 86:242-250. 2008
- The feasibility of in vivo measurement of arsenic and silver by x‐ray fluorescence. X-Ray Spectrometry. 37:51-57. 2008
- A method detection limit for potentialin vivoarsenic measurements with a 50 W x-ray tube. Physics in Medicine and Biology. 51:N381-N387. 2006
- SU‐FF‐T‐439: Treatment Planning to Achieve Skin Sparing with Tomotherapy. Medical Physics. 33:2146-2146. 2006
- Estimation of a method detection limit for anin vivoXRF arsenic detection system. Physics in Medicine and Biology. 50:521-530. 2005
- Polarization preservation in diffusive scattering from in vivo turbid biological media: effects of tissue optical absorption in the exact backscattering direction. Optics Communications. 190:37-43. 2001
- Methodology for examining polarized light interactions with tissues and tissuelike media in the exact backscattering direction. Journal of Biomedical Optics. 5:330-330. 2000